Drawing for OM PHARMA

USPTO serial 79123549

OM PHARMA

Reviewed by CopyMark Law Group

Reg. 4527414Status 404
Filing date
Status date
Registration date
May 13, 2014
Examiner
KIDWELL WALKER, JACLYN NOEMI
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OM PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary products for the treatment, alleviation and prevention of gastro-intestinal disorders, urinary tract disorders, kidney disorders, capillary hemorrhages, diabetic retinopathy, and venous insufficiency; pharmaceutical preparations for the treatment of gastrointestinal discomforts and gastrointestinal diseases, iron deficiency, disorders of the central nervous system, ophthalmic diseases, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, diabetes, and migraines and other forms of headache; analgesics; antivirals; anti-infectives; anti-inflamatories; antibiotics; antidepressants; anti-cancer pharmaceutical preparations; pharmaceutical preparations for transplantation and transplant related conditions; preparations for the treatment of immunologic diseases; preparations for the treatment of neurodegenerative diseases, water/electrolyte metabolism and other disorders associated with dialysis; medicated lotions for the skin and hair; decongestants and anti-histamines; pharmaceutical preparations used as immune system stimulators; scabicides; anti-malarials; cough suppressants; cough and cold preparations; expectorants; anti- leukemic agents; dermatologicals being medicated skin care preparations; tissue sealants; vasopressors; pharmaceutical preparations, namely, non-depolarizing skeletal neuromuscular blocking agents; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for cessation of smoking; pharmaceutical preparations for treatment of Parkinson's disease; vaccines; dietary supplement preparations containing unsaturated fatty acids, vitamins and minerals, nutraceuticals for use as a dietary supplement; antiemetics; disinfectants for wounds; nasal spray preparationsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 11, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Apr 11, 2021DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 26, 2021C71TCANCELLED SECTION 71—
Dec 3, 2019TMBNTTAB RELEASE CASE TO TRADEMARKS—
Dec 3, 2019CANTCANCELLATION TERMINATED NO. 999999—
Dec 3, 2019CANDCANCELLATION DENIED NO. 999999—
Jul 16, 2019PETCCANCELLATION INSTITUTED NO. 999999—
Oct 26, 2017CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 31, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 25, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 25, 2014FIMPFINAL DISPOSITION PROCESSED—
Aug 13, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 13, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2014GPNXNOTIFICATION PROCESSED BY IB—
Feb 5, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 5, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 5, 2014NPUBNOTICE OF PUBLICATION—
Jan 18, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 18, 2014ALIEASSIGNED TO LIE—
Dec 20, 2013CNEAEXAMINERS AMENDMENT MAILED—
Dec 20, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 20, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Dec 20, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 12, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 27, 2013CFRCSUBSEQUENT FINAL MAILED—
Jun 27, 2013CFRCSUBSEQUENT FINAL MAILED—
Jun 27, 2013CFRCSUBSEQUENT FINAL REFUSAL WRITTEN—
Jun 26, 2013CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 26, 2013CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 4, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 4, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2013RFNTREFUSAL PROCESSED BY IB—
Feb 1, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 1, 2013RFRRREFUSAL PROCESSED BY MPU—
Feb 1, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 31, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2013DOCKASSIGNED TO EXAMINER—
Jan 19, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 15, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 10, 2013SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance